Navigation Links
Nutraceutical Leader Announces Internal Promotions of Key Personnel
Date:9/2/2010

ST. LOUIS, Sept. 2 /PRNewswire/ -- ZeaVision, LLC announced two internal promotions as the company expands operations serving EyeCare Professionals and consumers with its leading EyePromise® nutraceutical products featuring Zeaxanthin.

Chris Barber has been promoted to President effective immediately from his previous role of Vice President Sales and Marketing. His promotion also includes appointment to the ZeaVision Executive Board. Founder, Chairman, and Chief Science Officer Dennis Gierhart, PhD adds, "Chris exemplifies ZeaVision's corporate values and brings enthusiasm, expertise, and extensive business experience to ZeaVision."

Prior to joining ZeaVision, Barber worked as a commercial leader for GE Healthcare and legacy companies for 27 years. Barber received a Bachelor of Business Administration degree from the University of Central AR and executive training at The University of Chicago, University of Michigan, and the GE Executive development center.  

ZeaVision also announced that Betsy Ley has been promoted to Director of Marketing and Customer Service effective immediately. Ley has managed ZeaVision Customer Service since joining the company in 2005, and has more than 25 years of experience in a variety of roles at Com-Link21, LDDS, MCI WorldCom, Maritz Inc., and CallForceOne Consulting Group. Gierhart commented, "Betsy understands the needs of our customers extremely well and we're excited to expand her responsibilities within the ZeaVision business."  

Photo of Chris Barber: http://www.ereleases.com/pic/Chris-Barber.jpg

Photo of Betsy Ley: http://www.ereleases.com/pic/Betsy-Ley.gif

About ZeaVision ZeaVision is Passionate About Prevention and develops nutraceutical products for EyeCare Professionals and patients for managing Age-related Macular Degeneration (AMD) risk factors to maintain healthy vision. The company holds patents on Zeaxanthin, which is prominently featured in its EyePromise® Supplements. ZeaVision also markets QuantifEye, a testing device that measures macular pigment as well Eye-Q, the company's comprehensive AMD Risk Management program. For more information, please visit http://www.zeavision.com or call 866-833-2800.

ZeaVision, EyePromise, QuantifEye, and Eye-Q are the respective logos and registered trademarks of ZeaVision, LLC. All other trademarks herein are properties of their respective owners. All rights reserved.Contact: Betsy LeyDirector of MarketingZeaVision314-628-1000bley@zeavision.com This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>

SOURCE ZeaVision, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Internal Consulting Organizations Need to Show Value to Organizational Leadership
2. Baxa Corporation Recognized for Pharmacy Automation Leadership and Business Growth
3. The SCOOTER Store Partners With Branding Leader
4. Pharma and Food Thought Leaders Set to Converge in Amsterdam Next April 2011
5. Leaders to Discuss Future of Healthcare and Technology on Aug. 24
6. Medco Announces Agreement to Acquire United BioSource Corporation: A Global Medical Research and Scientific Services Leader to Advance Drug Safety and Knowledge
7. Pascal Metrics Welcomes Jim Conway to Leadership Team as Principal
8. Codexis to Present at the Pacific Crest Technology Leadership Forum
9. Education Tactics for Thought Leaders, Physicians, Patients and Payers to Support Successful Oncology Product Launches
10. CAP Leaders Stress Need for Oversight of Direct-to-Consumer and Laboratory Developed Tests
11. Sysmex America Announces Executive Leadership Changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/9/2017)... ... ... – Monday, September 18 th .The Brain Tumor Foundation (BTF) begins ... the public.Where:  BTF,s Mobile MRI Unit – a ... Washington, D.C.What:BTF brings its nationwide initiative, the Road to Early Detection Sponsor-A-City ...
(Date:9/9/2017)... Lilly and Company (NYSE: LLY ) will ... an investigational, oral, first-in-class molecule for the acute treatment ... placebo in the Phase 3 SPARTAN study. Detailed results ... the International Headache Society (IHC) in Vancouver ... lasmiditan,s potential to reduce pain and provide freedom from ...
(Date:9/7/2017)... MIRAGE, Calif. , Sept. 7, 2017  For nearly two decades, ... service in the Assisted Reproduction Insurance industry. Today, New Life Agency announces ... fertility medications. ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ... ...
Breaking Medicine Technology:
(Date:9/22/2017)... ... September 22, 2017 , ... Silicon Valley ... even on the go. Their electric toothbrushes aggressively attack oral bacteria by reducing ... sanitizing technology. Combining leading edge Enke technology with a premium timeless design, they ...
(Date:9/22/2017)... ... September 22, 2017 , ... “Letters From Home”: a moving ... lost, have value to God. “Letters From Home” is the creation of published author, ... the President’s Cabinet of Jerry Savelle Ministries International, who has traveled and ministered on ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... and create life. Although frozen embryos have a slight statistical advantage for live ... freezing is a wonderful opportunity for women undergoing medical treatment or who are ...
(Date:9/21/2017)... ... 21, 2017 , ... With ProSlideshow Portrait from Pixel Film Studios creating a ... select from up to two layers of subject matter along with fully customizable backdrop ... Final Cut Pro X. , With ProSlideshow Portrait each user are given ...
(Date:9/21/2017)... ... 21, 2017 , ... Process Capability Indices for Medical Device ... ET, http://www.fdanews.com/processcapabilityindices      , Quality in device manufacturing is ... Quality System Regulation (§820.250), and Devicemakers find themselves staring at a warning letter. ...
Breaking Medicine News(10 mins):